Premium
Hypermethylation of hMLH1 , HPP1 , p14 ARF , p16 INK4A and APC in primary adenocarcinomas of the small bowel
Author(s) -
Brücher Björn L.D.M.,
Geddert Helene,
Langner Cord,
Höfler Heinz,
Fink Ulrich,
R. Siewert Jörg,
Sarbia Mario
Publication year - 2006
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.21990
Subject(s) - dna methylation , methylation , adenocarcinoma , biology , carcinogenesis , epigenetics , cancer research , cancer , gene , genetics , gene expression
Small bowel adenocarcinoma (SB‐AC) is a very rare tumor entity. Epigenetic alterations, including hypermethylation of DNA mismatch repair genes and tumor suppressor genes, seem to be important for carcinogenesis in tumors of the gastrointestinal tract, but have not yet been investigated in SB‐AC. In the current study, the prevalence of hypermethylation in a panel of genes involved in gastrointestinal carcinogenesis ( hMLH1 , HPP1 , p14 ARF , p16 INK4A , APC ) was determined in a series of SB‐AC. Paraffin‐embedded tumor samples from 56 patients with SB‐AC who underwent surgical resection between January 1985 and December 2003 were investigated for hypermethylation by means of methylation‐specific real‐time PCR, and compared with our findings in a previously investigated series of 50 gastric adenocarcinomas. In comparison with adenocarcinomas of the stomach, SB‐AC revealed a significantly higher rate of hypermethylation of HPP1 (86% versus 54%, p = 0.0003), p16 INK4A (32% versus 10%, p = 0.0006), and a significantly lower rate of hypermethylation of APC (48% versus 84%, p = 0.0001). Hypermethylation of hMLH1 and p14 ARF was present in 23% and 9% of SB‐AC, respectively. Locally advanced tumor categories (pT3/4) showed a higher rate of hypermethylation of HPP1 (90%) than did early tumor categories (pT1/2 categories, 40%; p = 0.0036). This was also reflected by the correlation between the HPP1 hypermethylation and high UICC stage ( p = 0.02). No correlation was found between hypermethylation and other clinicopathologic parameters such as age, tumor grade and nodal status. Our findings suggest that hypermethylation of hMLH1 , HPP1 , p16 INK4A and APC is frequent in primary adenocarcinomas of the small bowel. The differences in the hypermethylation spectrum of small bowel and stomach cancer indicate significant epigenetic differences between these tumors. © 2006 Wiley‐Liss, Inc.